Merck awarded more than $180 million against Apotex for infringement of Lovastatin patent – Lexology.
Generic ordered to pay $1.7 million in accounting of profits – Lexology.
A further limitation on the ability of the generic drug companies to chase the profits of innovators? – Lexology.
IP owners may avoid invalidity challenges with covenants not to sue – Lexology.
General Licensing Practices and the Nature of an Infringing Product May Affect the Ability to Obtain a Permanent Injunction.